Amount of milestone obligation in connection with asset acquisition.

No definition available.

Name:	alms_AssetAcquisitionMilestoneObligation
Namespace Prefix:	alms_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of milestone payment made in connection with asset acquisition.

+ References

No definition available.

+ Details

Name:	alms_AssetAcquisitionPaymentOfMilestone
Namespace Prefix:	alms_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of liability recognized from contingent consideration in asset acquisition.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 15
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480123/805-50-15-3

+ Details

Name:	us-gaap_AssetAcquisitionContingentConsiderationLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

Name:	us-gaap_AssetAcquisitionContingentConsiderationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_AssetAcquisitionAxis=alms_FrontheraUsHoldingsIncAndFrontheraUsPharmaceuticalsLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=alms_ClinicalMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=alms_ApprovalMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingent Liabilities - FronThera Contingent Consideration (Details) - FronThera - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Aug. 31, 2024	Dec. 31, 2022	Dec. 31, 2024	Mar. 31, 2021
FronThera Contingent Consideration
Milestone payment obligation			$ 0.0
Clinical milestones
FronThera Contingent Consideration
Contingent consideration liability				$ 120.0
Milestone payment made	$ 23.0	$ 37.0
Milestone payment obligation				70.0
Approval milestones \| Maximum
FronThera Contingent Consideration
Milestone payment obligation				$ 50.0